If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding

van Brummelen, E. M. J., Huisman, M. C., de Wit-van der Veen, L. J., Nayak, T. K., Stokkel, M. P. M., Mulder, E. R., Hoekstra, O. S., Vugts, D. J., Van Dongen, G. A. M. S., Verheul, H. M., Evers, S., Tessier, J. J. L., Saro, J., Schellens, J. H. M. & Menke-van der Houven van Oordt, C. W., 15 May 2018, In : Oncotarget. 9, 37, p. 24737-24749 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial

Bouman-Wammes, E. W., van den Berg, H. P., de Munck, L., Beeker, A., Smorenburg, C. H., Vervenne, W. L., Coenen, J. L. L. M., Verheul, H. M. W., Gerritsen, W. R. & van den Eertwegh, A. J. M., 2018, In : European Journal of Cancer. 90, p. 1-9

Research output: Contribution to journalArticleAcademicpeer-review

Are patient-reported outcomes of physical function a valid substitute for objective measurements?

Douma, J. A. J., Verheul, H. M. W. & Buffart, L. M., 2018, In : Current oncology (Toronto, Ont.). 25, 5, p. e475-e479

Research output: Contribution to journalArticleAcademicpeer-review

A safety and immunogenicity study of immunization with hVEGF/RFASE in cynomolgus monkeys

Wentink, M. Q., Verheul, H. M. W., Griffioen, A. W., Schafer, K. A., McPherson, S., Early, R. J., van der Vliet, H. J. & de Gruijl, T. D., 5 Apr 2018, In : Vaccine. 36, 15, p. 2025-2032 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Activities 2017 2017

  • 1 Oral presentation

Rapid development of peritoneal metastases after adjuvant chemotherapy is associated with worse survival after cytoreduction and HIPEC.

Sluiter, N. R. (Speaker), Y Salhi (Speaker), Kazemier, G. (Speaker), Verheul, H. (Speaker), Tuynman, J. B. (Speaker)
Sep 2017

Activity: Talk or presentationOral presentation